ROKIT AMERICA

AI-Powered Precision Platform
for Patient-Specific 3D Printing Technology

Patient-specific 3D Printing Technology

to support tissue reconstruction and enhance regenerative therapy options for complex defects through cutting-edge biomedical innovation.

This integrated solution combines, AI-assisted software, high-precision 3D bioprinting technology, and specialized KIT to facilitate patient-specific treatments. By converging multidisciplinary expertise, our platform aims to advance the standard of care in precision medicine, providing clinicians with transformative tools for complex clinical needs in leading medical institutions.

Patient-specific Organ Regeneration Platform

Our Vision

Today, the global healthcare landscape remains predominantly focused on the management of chronic diseases. Standard treatments often prioritize symptom relief and slowing disease progression rather than addressing the functional deficits. While these clinical approaches provide essential support, patients still face a lifelong journey of medication dependency or the challenging reality of transplant waiting lists.

We strive to provide advanced solutions designed to deliver true support and lasting tissue restoration, offering patients worldwide a path that complements traditional management with regenerative possibilities.

The Paradigm Shift: The Seed & Soil Philosophy

ROKIT America is spearheading a paradigm shift in medicine through our AI-driven personalized organ (Skin tissue, Cartilage tissue, Kidney renal) regeneration platform, advancing beyond the traditional management of complex wounds.

Guided by the 'Seed and Soil' principle, our platform optimizes the biological 'soil'—the essential internal environment—to preserve and empower the 'seeds' of the body’s natural regenerative potential. By evolving from conventional one-size-fits-all models for complex wound treatment with a technology-driven, personalized approach, we are redefining the healthcare landscape and striving to enhance the quality of life for patients.

Platform Overview

Our patient's own tissue reconstructive specific organ regeneration platform is a reconstructive medicine solution that integrates automated AI-assisted wound modeling application, 3D bioprinting, and proprietary technology that processes patient-specific ECM into customized bio-inks.

By leveraging the power of a patient’s own biological data and cells, we create biocompatible tissues designed to reduce the risk of immune rejection and support the restoration of areas damaged by complex wound. We are bridging the gap between technological innovation and clinical application to make on-demand tissue restoration a reality, providing solution for patients seeking vital therapeutic options.

3D-Printer (Dispenser)

Dr. INVIVO

Utilizing regenerative bio-ink derived from the patient’s ECM, we produce an AI-optimized, '3D Printed matrix' that is applied to the wound site to promote functional tissue restoration.

Disposable Medical Device KIT

Dr. INVIVO Scaffold KIT

Promotes effective tissue restoration by precisely redelivering autologous fat-derived bio-inks to the patient's wound site.

AI-Assisted Software Application

AiD Regen

Optimizes the wound assessment for clinical intervention by leveraging the AiD Regen, which performs high-precision 3D scanning and automated digital reconstruction of the wound.

* Product names and/or product components may vary according to country-specific regulatory approvals.

Synergy that Scales

Partnership / Clinical Inquires

Contact our team

Application Pipelines

Target application: Diabetic Foot Ulcer (DFU)
Expanding its scope and securing clinical data in reconstruction after non-melanoma skin cancer resection (post-resection wounds), burns, pressure ulcers, and traumatic wounds.

Skin

Precision Reconstruction of Complex Wound

Moving beyond the limitations of conventional treatments—such as repetitive procedures, low clinical efficiency, prolonged hospitalization, and post-surgical scarring—Skin Regeneration Platform introduces a streamlined, next-generation approach to wound healing.

Our Skin Regeneration Platform utilizes AI-driven wounds modeling to fabricate and apply ‘3D printed matrix (patch)’ optimized for each patient's specific wound shape.

By providing a microenvironment that supports cell proliferation, the platform protects the wound site while simultaneously promoting functional tissue restoration, aiming to regenerate skin structure and integrity beyond conventional management.

Disclaimer :

All information regarding the Cartilage and Kidney platforms is currently under clinical evaluation or research. These products have not yet been evaluated or approved by the U.S. FDA, though we are preparing for the regulatory submission process. The terms “organ regeneration”, “skin regeneration”, “cartilage regeneration”, “kidney regeneration” may be used in a general or conceptual manner and do not constitute clinical or therapeutic claims.

Publication

0Papers

Category	Title	Year